VILYA
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.
VILYA
Industry:
Biotechnology Health Diagnostics Life Science Medical
Founded:
2022-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.vilyatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
71 M USD
Technology used in webpage:
Google Google Cloud CrUX Dataset CrUX Top 10m Google Cloud Global Multi-Region
Similar Organizations
Applied StemCell
Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.
Benitec Ltd
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
NVentures
NVentures investment in Series A - Vilya
Madrona
Madrona investment in Series A - Vilya
Lifeforce Capital
Lifeforce Capital investment in Series A - Vilya
Menlo Ventures
Menlo Ventures investment in Series A - Vilya
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series A - Vilya
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Vilya
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Vilya
Key Employee Changes
| Date | New article |
|---|---|
| 2023-10-20 | Co-founded by David Baker, Vilya rings in a permanent CEO; Allogene names Eric Schmidt's CFO successor |
Official Site Inspections
http://www.vilyatx.com Semrush global rank: 7.24 M Semrush visits lastest month: 850
- Host name: 245.105.62.166.host.secureserver.net
- IP address: 166.62.105.245
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Vilya"
COMPUTE BEYOND NATURE - VILYA
Our platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space to design new molecular structures not found in nature.See details»
Vilya - Crunchbase Company Profile & Funding
Contact Email [email protected] Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput …See details»
Vilya - LinkedIn
Vilya is a cutting-edge computational biotechnology company, co-founded a team of scientists from from the Institute of Protein Design (IPD) led by David Baker, Ph.D. and by ARCH Venture Partners.See details»
Vilya Company Profile 2024: Valuation, Funding
Vilya General Information Description. Developer of a biotechnology platform designed for creating a novel class of medicines to precisely target disease biology. The company's platform taps into uncharted chemical space to design …See details»
Vilya - VentureRadar
"Vilya is a computational biotechnology company creating a novel class of medicines to precisely target disease biology. The Company’s proprietary platform, powered by advanced machine …See details»
Vilya: Contact Details and Business Profile - RocketReach
Vilyatx.com; 1 406381XXXX; View Similar People. Related Companies Epic Systems Corporation. 66 $3.3b Anduril Industries. 2,139 South Western Bell Telephone. 22 Wunderman. 2,547 …See details»
Vilya Company Profile - Office Locations, Competitors, Revenue
Vilya has 5 employees at their 1 location and $50 m in total funding,. See insights on Vilya including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Vilya | Company | Mindmaps
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.See details»
Vilya CEO and Key Executive Team | Craft.co
Vilya's Chief Executive Officer is Cyrus Harmon. Other executives include Katerina Leftheris, Chief Scientific Officer; Patrick Salveson, Co-Founder & VP of Research and Discovery and 7 …See details»
Vilya Expands Series A Financing to $71 Million to Advance ...
Vilya was co-founded by a team of scientists from the Institute of Protein Design (IPD) led by David Baker, Ph.D., and ARCH Venture Partners. The company has operations in Seattle and …See details»
Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer
Oct 17, 2023 SEATTLE--(BUSINESS WIRE)--VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the …See details»
Vilya - Company info. interviews, news - biopharmatrend.com
Vilya is a computational biotechnology company creating a novel class of medicines to precisely target disease biology. Our platform is built on ground-breaking research in advanced …See details»
Vilya | F6S
Similar companies Enveda Biosciences Engineering New Drugs from Nature VYO RESEARCH A natural product based solution developer/provider for Health & FMCGsector Zavia Bio …See details»
Vilya Launches to Design a New Transformational Class of …
Aug 29, 2022 A team of scientists at Institute of Protein Design led by David Baker, Ph.D., and ARCH Venture Partners launch Vilya to create a new transformational class of medicinesSee details»
Vilya Expands Series A Financing to $71 Million to Advance
Jun 4, 2024 The company has operations in Seattle and South San Francisco. To learn more, visit https://www.vilyatx.com and follow Vilya on LinkedIn. Media Contact Julie NormartSee details»
Vilya Expands Series A Financing to $71 Million to Advance ...
Jun 4, 2024 Vilya was co-founded by a team of scientists from the Institute of Protein Design (IPD) led by David Baker, Ph.D., and ARCH Venture Partners. The company has operations in …See details»
Vilya Expands Series A Financing to $71 Million to Advance ...
SEATTLE, June 04, 2024 (GLOBE NEWSWIRE) -- VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, announced today an …See details»
Vilya Launches to Design a New Transformational Class of
Aug 29, 2022 Vilya is leveraging its platform to focus on previously difficult-to-drug therapeutic targets. Vilya was co-founded by a team of scientists from the Institute of Protein Design (IPD) …See details»
JOIN US - VILYA - vilyatx.com
Are you motivated by curing disease and creating novel medicines? Join us to push the boundaries of computation and medicine.See details»
Did you recently visit vilyatx.com? Read this now!
Organization Unit vilyatx.com; PERIOD OF VALIDITY. SSL Certificate valid from: 27/08/2022 (2 years ago) To: 28/09/2023 (1 year ago) Info: An SSL certificate is used to keep sensitive …See details»